These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. The pluripotency factor Nanog is directly upregulated by the androgen receptor in prostate cancer cells. Kregel S; Szmulewitz RZ; Vander Griend DJ Prostate; 2014 Nov; 74(15):1530-43. PubMed ID: 25175748 [TBL] [Abstract][Full Text] [Related]
23. Prolonged androgen receptor loading onto chromatin and the efficient recruitment of p160 coactivators contribute to androgen-independent growth of prostate cancer cells. Shi XB; Xue L; Zou JX; Gandour-Edwards R; Chen H; deVere White RW Prostate; 2008 Dec; 68(16):1816-26. PubMed ID: 18780293 [TBL] [Abstract][Full Text] [Related]
24. The NLR-related protein NWD1 is associated with prostate cancer and modulates androgen receptor signaling. Correa RG; Krajewska M; Ware CF; Gerlic M; Reed JC Oncotarget; 2014 Mar; 5(6):1666-82. PubMed ID: 24681825 [TBL] [Abstract][Full Text] [Related]
25. Effects of miR-103a-3p Targeted Regulation of TRIM66 Axis on Docetaxel Resistance and Glycolysis in Prostate Cancer Cells. Yi Q; Wei J; Li Y Front Genet; 2021; 12():813793. PubMed ID: 35211152 [No Abstract] [Full Text] [Related]
26. Capillarisin blocks prostate-specific antigen expression on activation of androgen receptor in prostate carcinoma cells. Tsui KH; Chang YL; Feng TH; Hou CP; Lin YH; Yang PS; Lee BW; Juang HH Prostate; 2018 Mar; 78(4):242-249. PubMed ID: 29164633 [TBL] [Abstract][Full Text] [Related]
27. NDRG2 acts as a negative regulator downstream of androgen receptor and inhibits the growth of androgen-dependent and castration-resistant prostate cancer. Yu C; Wu G; Li R; Gao L; Yang F; Zhao Y; Zhang J; Zhang R; Zhang J; Yao L; Yuan J; Li X Cancer Biol Ther; 2015; 16(2):287-96. PubMed ID: 25756511 [TBL] [Abstract][Full Text] [Related]
28. Estrogen induces androgen-repressed SOX4 expression to promote progression of prostate cancer cells. Yang M; Wang J; Wang L; Shen C; Su B; Qi M; Hu J; Gao W; Tan W; Han B Prostate; 2015 Sep; 75(13):1363-75. PubMed ID: 26015225 [TBL] [Abstract][Full Text] [Related]
29. Androgen receptor and chemokine receptors 4 and 7 form a signaling axis to regulate CXCL12-dependent cellular motility. Hsiao JJ; Ng BH; Smits MM; Wang J; Jasavala RJ; Martinez HD; Lee J; Alston JJ; Misonou H; Trimmer JS; Wright ME BMC Cancer; 2015 Mar; 15():204. PubMed ID: 25884570 [TBL] [Abstract][Full Text] [Related]
30. Antitumor activity of NF-kB decoy oligodeoxynucleotides in a prostate cancer cell line. Fang Y; Sun H; Zhai J; Zhang Y; Yi S; Hao G; Wang T Asian Pac J Cancer Prev; 2011; 12(10):2721-6. PubMed ID: 22320981 [TBL] [Abstract][Full Text] [Related]
31. Role of androgen receptor in the progression of human prostate tumor cells to androgen independence and insensitivity. Kokontis JM; Hsu S; Chuu CP; Dang M; Fukuchi J; Hiipakka RA; Liao S Prostate; 2005 Dec; 65(4):287-98. PubMed ID: 16015608 [TBL] [Abstract][Full Text] [Related]
32. Androgen receptor-dependent regulation of Bcl-xL expression: Implication in prostate cancer progression. Sun A; Tang J; Hong Y; Song J; Terranova PF; Thrasher JB; Svojanovsky S; Wang HG; Li B Prostate; 2008 Mar; 68(4):453-61. PubMed ID: 18196538 [TBL] [Abstract][Full Text] [Related]
33. A regulatory circuit HP1γ/miR-451a/c-Myc promotes prostate cancer progression. Chang C; Liu J; He W; Qu M; Huang X; Deng Y; Shen L; Zhao X; Guo H; Jiang J; Fu XY; Huang R; Zhang D; Yan J Oncogene; 2018 Jan; 37(4):415-426. PubMed ID: 28967902 [TBL] [Abstract][Full Text] [Related]
34. Sensitization of androgen refractory prostate cancer cells to anti-androgens through re-expression of epigenetically repressed androgen receptor - Synergistic action of quercetin and curcumin. Sharma V; Kumar L; Mohanty SK; Maikhuri JP; Rajender S; Gupta G Mol Cell Endocrinol; 2016 Aug; 431():12-23. PubMed ID: 27132804 [TBL] [Abstract][Full Text] [Related]
35. Androgenic up-regulation of androgen receptor cDNA expression in androgen-independent prostate cancer cells. Dai JL; Maiorino CA; Gkonos PJ; Burnstein KL Steroids; 1996 Sep; 61(9):531-9. PubMed ID: 8883219 [TBL] [Abstract][Full Text] [Related]
36. Tumor necrosis factor-alpha represses androgen sensitivity in the LNCaP prostate cancer cell line. Mizokami A; Gotoh A; Yamada H; Keller ET; Matsumoto T J Urol; 2000 Sep; 164(3 Pt 1):800-5. PubMed ID: 10953159 [TBL] [Abstract][Full Text] [Related]
37. Identification of kinases regulating prostate cancer cell growth using an RNAi phenotypic screen. Whitworth H; Bhadel S; Ivey M; Conaway M; Spencer A; Hernan R; Holemon H; Gioeli D PLoS One; 2012; 7(6):e38950. PubMed ID: 22761715 [TBL] [Abstract][Full Text] [Related]
38. Sulforaphane increases the efficacy of anti-androgens by rapidly decreasing androgen receptor levels in prostate cancer cells. Khurana N; Talwar S; Chandra PK; Sharma P; Abdel-Mageed AB; Mondal D; Sikka SC Int J Oncol; 2016 Oct; 49(4):1609-19. PubMed ID: 27499349 [TBL] [Abstract][Full Text] [Related]
39. Nkx3.1 and p27(KIP1) cooperate in proliferation inhibition and apoptosis induction in human androgen-independent prostate cancer cells. Wang P; Ma Q; Luo J; Liu B; Tan F; Zhang Z; Chen Z Cancer Invest; 2009 May; 27(4):369-75. PubMed ID: 19266349 [TBL] [Abstract][Full Text] [Related]
40. The novel long noncoding RNA LOC283070 is involved in the transition of LNCaP cells into androgen-independent cells via its interaction with PHB2. Zhang Y; Wang LN; Lin YN; Xing YX; Shi Y; Zhao J; Chen WW; Han B Asian J Androl; 2018; 20(5):511-517. PubMed ID: 29956684 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]